StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 730.00
-5.00 (-0.68%)
May 12, 2026, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 7.48 billion as of May 12, 2026. Its market cap has decreased by -44.27% in one year.
Market Cap
7.48B
Enterprise Value
5.30B
Revenue
2.78B
Ranking
n/a
PE Ratio
38.54
Stock Price
730.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 7.48B, a decrease of -64.65%. That is a compound annual growth rate of -19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.53B | -7.31% |
| Dec 30, 2025 | 8.13B | -38.48% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.77B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| ADR120S | 7.31B |
| CellSource | 7.18B |
| Chiome Bioscience | 7.02B |
| TMS Co., Ltd. | 6.87B |